This page shows the latest Dayvigo news and features for those working in and with pharma, biotech and healthcare.
Since then, it’s been joined on the market by Eisai’s recently-approved Dayvigo (lemborexant), which is also being tested in Alzheimer’s-relate sleep disturbances and reported positive results
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...